Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.02 EUR
33.73 M EUR
262.51 M EUR
71.44 M
About JCR PHARMACEUTICAL CO
Sector
CEO
Shin Ashida
Headquarters
Ashiya
Website
Founded
1975
ISIN
JP3701000006
FIGI
BBG000LJ4TM2
JCR Pharmaceuticals Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following segment Pharmaceutical Business. The Pharmaceutical Business segment deals with the manufacture, purchase, and sale of ethical drugs, active pharmaceutical ingredients, raw materials, import and export of medical devices and laboratory instruments . The company was founded by Shin Ashida on September 13, 1975 and is headquartered in Ashiya, Japan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of JCR is 4.02 EUR — it has decreased by −3.37% in the past 24 hours. Watch JCR PHARM. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange JCR PHARM. stocks are traded under the ticker JCR.
JCR stock has fallen by −0.99% compared to the previous week, the last month showed zero change in price, over the last year there was no change in JCR PHARM. price.
We've gathered analysts' opinions on JCR PHARM. future price: according to them, JCR price has a max estimate of 12.08 EUR and a min estimate of 3.63 EUR. Watch JCR chart and read a more detailed JCR PHARM. stock forecast: see what analysts think of JCR PHARM. and suggest that you do with its stocks.
JCR stock is 3.48% volatile and has beta coefficient of 0.78. Track JCR PHARM. stock price on the chart and check out the list of the most volatile stocks — is JCR PHARM. there?
Today JCR PHARM. has the market capitalization of 535.41 M, it has increased by 5.68% over the last week.
Yes, you can track JCR PHARM. financials in yearly and quarterly reports right on TradingView.
JCR PHARM. is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
JCR earnings for the last quarter are −0.04 EUR per share, whereas the estimation was 0.09 EUR resulting in a −152.04% surprise. The estimated earnings for the next quarter are 0.01 EUR per share. See more details about JCR PHARM. earnings.
JCR PHARM. revenue for the last quarter amounts to 53.19 M EUR, despite the estimated figure of 70.33 M EUR. In the next quarter, revenue is expected to reach 56.62 M EUR.
JCR net income for the last quarter is −5.57 M EUR, while the quarter before that showed 1.17 M EUR of net income which accounts for −577.59% change. Track more JCR PHARM. financial stats to get the full picture.
JCR PHARM. dividend yield was 2.33% in 2023, and payout ratio reached 45.32%. The year before the numbers were 1.42% and 65.91% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 8, 2024, the company has 934.00 employees. See our rating of the largest employees — is JCR PHARM. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JCR PHARM. EBITDA is 20.06 M EUR, and current EBITDA margin is 25.03%. See more stats in JCR PHARM. financial statements.
Like other stocks, JCR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JCR PHARM. stock right from TradingView charts — choose your broker and connect to your account.